Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-21 Sale | 2024-11-25 4:05 pm | Cyclerion Therapeutics Inc. | CYCN | Slate Path Capital LP Greenspan David Gerald 10% Owner | 357,880 | $1.5511 | $555,108 | 0 (Indirect) | View |
| 2023-08-09 Sale | 2023-08-11 4:25 pm | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 8 | $3.395 | $27 | 37,010 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-09 Option Award | 2026-09-10 5:45 pm | N/A 2036-09-09 | Korsana Biosciences Inc. | KRSA | Pernice Michelle Patricia Director | 48,445 | $0 | 48,445 (Direct) | View |
| 2026-09-09 Option Award | 2026-09-10 5:45 pm | N/A 2036-09-09 | Korsana Biosciences Inc. | KRSA | Shah Nimish P Director | 48,445 | $0 | 48,445 (Direct) | View |
| 2026-09-09 Option Award | 2026-09-10 5:44 pm | N/A 2036-09-09 | Korsana Biosciences Inc. | KRSA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest VI L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 48,445 | $0 | 48,445 (Indirect) | View |
| 2026-09-09 Option Award | 2026-09-10 5:43 pm | N/A 2036-09-09 | Korsana Biosciences Inc. | KRSA | Gottesdiener Andrew Director | 48,445 | $0 | 48,445 (Direct) | View |
Ownership | 2026-09-10 5:36 pm | N/A N/A | Korsana Biosciences Inc. | KRSA | Violin Jonathan See Remarks | 0 | $0 | 3,239,801 (Direct) | View |
Ownership | 2026-09-10 5:36 pm | N/A 2036-06-07 | Korsana Biosciences Inc. | KRSA | Leoni Matthew James Chief Medical Officer | 0 | $0 | 647,729 (Direct) | View |
Ownership | 2026-09-10 5:34 pm | N/A 2035-10-26 | Korsana Biosciences Inc. | KRSA | Pernice Michelle Patricia Director | 0 | $0 | 28,805 (Direct) | View |
Ownership | 2026-09-10 5:34 pm | N/A 2036-06-29 | Korsana Biosciences Inc. | KRSA | HENSON HEIDI Director | 0 | $0 | 100,994 (Direct) | View |
Ownership | 2026-09-10 5:30 pm | N/A N/A | Korsana Biosciences Inc. | KRSA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest VI L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 11,244,165 (Indirect) | View |
Ownership | 2026-09-10 5:29 pm | N/A N/A | Korsana Biosciences Inc. | KRSA | Shah Nimish P Director | 0 | $0 | 9,762,629 (Indirect) | View |
Ownership | 2026-09-10 5:26 pm | N/A 2036-03-08 | Korsana Biosciences Inc. | KRSA | Vignola Mark J. Chief Financial Officer | 0 | $0 | 647,729 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 5:27 pm | N/A 2035-08-06 | Cyclerion Therapeutics Inc. | CYCN | CHICKO RHONDA M. Chief Financial Officer | 25,000 | $0 | 25,018 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 5:27 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | CHICKO RHONDA M. Chief Financial Officer | 25,000 | $2.355 | 25,018 (Direct) | View |
| 2026-08-14 Tax Withholding | 2026-08-18 5:21 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret See Remarks | 48,629 | $3.79 | 107,523 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 5:21 pm | N/A 2034-08-03 | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret See Remarks | 55,849 | $0 | 107,523 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 5:21 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret See Remarks | 55,849 | $3.3 | 107,523 (Direct) | View |
| 2026-07-16 Conversion | 2026-07-20 5:04 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner | 351,037 | $0 | 910,312 (Direct) | View |
| 2025-08-07 Option Award | 2025-08-11 4:05 pm | N/A 2035-08-06 | Cyclerion Therapeutics Inc. | CYCN | CHICKO RHONDA M. Chief Financial Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-03-25 Option Award | 2025-03-27 8:38 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner | 181,818 | $2.75 | 559,275 (Direct) | View |
| 2025-03-25 Option Award | 2025-03-27 4:20 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Higgins Michael J Director | 9,090 | $2.75 | 30,740 (Direct) | View |
| 2024-08-05 Option Award | 2024-08-07 4:05 pm | N/A 2034-08-05 | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret See Remarks | 55,849 | $0 | 55,849 (Direct) | View |
Ownership | 2024-03-11 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | CHICKO RHONDA M. Chief Financial Officer | 0 | $0 | 18 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-26 4:07 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner | 15,000 | $0 | 377,457 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-26 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President | 50,000 | $0 | 100,303 (Direct) | View |
Ownership | 2023-12-11 5:09 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Katabi Dina Director | 0 | $0 | 20,000 (Direct) | View |
Ownership | 2023-12-07 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Higgins Michael J Director | 0 | $0 | 21,650 (Direct) | View |
Ownership(A) | 2023-12-07 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President | 0 | $0 | 50,303 (Direct) | View |
Ownership | 2023-12-04 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President | 0 | $0 | 50,000 (Direct) | View |
| 2023-11-30 Option Award | 2023-12-04 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 5,000 | $0 | 42,010 (Direct) | View |
| 2023-11-30 Option Award | 2023-12-04 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner | 35,000 | $0 | 362,457 (Direct) | View |
| 2023-11-30 Option Award | 2023-12-04 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director | 50,000 | $0 | 30,000 (Direct) | View |
| 2023-11-30 Option Award | 2023-12-04 4:04 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 8:43 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer 10% Owner | 576,037 | $8.68 | 678,494 (Direct) | View |
| 2022-07-25 Option Award(A) | 2022-07-27 4:40 pm | N/A 2032-07-25 | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 57,753 | $0 | 57,753 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-26 4:33 pm | N/A 2032-07-25 | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 57,753 | $0 | 57,753 (Direct) | View |
Ownership | 2022-07-26 4:30 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 0 | $0 | 0 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Mendelsohn Michael Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Fanucci Marsha Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Lovell Stephanie Director | 20,000 | $0 | 20,000 (Direct) | View |